Comparison of the Dyspnoea-12 and Multidimensional Dyspnoea Profile in people with COPD

European Respiratory Journal

Volumn 49, Issue 3, 2017, Pages

  Williams, Marie T ^a   Johnn, David ^a   Frith, Peter ^a,b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b Southern Adelaide Health Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DYSPNEA; DYSPNEA 12; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIDIMENSIONAL DYSPNEA PROFILE; PREDICTION; RESPIRATORY TRACT DISEASE ASSESSMENT; SELF REPORT; SIX MINUTE WALK TEST; VISUAL ANALOG SCALE; AUSTRALIA; COMPLICATION; CROSS-SECTIONAL STUDY; FACTOR ANALYSIS; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOMETRY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; VALIDATION STUDY; WALK TEST;

AGED; AUSTRALIA; CROSS-SECTIONAL STUDIES; DYSPNEA; FACTOR ANALYSIS, STATISTICAL; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; WALK TEST;

EID: 85014488963     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00773-2016     Document Type: Conference Paper

References (42)

1. Williams MT, Garrard A, Cafarella P, et al. Quality of recalled dyspnoea is different from exercise induced dyspnoea: an experimental study. Aust J Physiother 2009; 55: 177-183.
2. Nishimura K, Yasui M, Nishimura T, et al. Airflow limitation or static hyperinflation: which is more closely related to dyspnea with activities of daily living in patients with COPD? Respir Res 2011; 12: 135.
3. Parshall MB, Schwartzstein RM, Adams L, et al. An Official Thoracic Society Statement: update on the mechanism, assessment and management of dyspnea. Am J Respir Crit Care Med 2012; 185: 435-452.
4. Williams MT, Cafarella P, Olds T, et al. Affective descriptors of sensations of breathlessness are more highly associated with severity of impairments than physical descriptors in people with COPD. Chest 2010; 138: 315-322.
5. Laveneziana P, Webb KA, Wadell K, et al. Does expiratory muscle activity influence dynamic hyperinflation and exertional dyspnea in COPD? Respir Physiol Neurobiol 2014; 199: 24-33.
6. Laveneziana P, Webb KA, Ora J, et al. Evolution of dyspnea during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011; 184: 1367-1373.
7. Mahler DA, Harver A, Lentine T, et al. Descriptors of breathlessness in cardiorespiratory diseases. Am J Respir Crit Care Med 1996; 154: 1357-1363.
8. Yorke J, Moosavi SH, Shuldham C, et al. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 2010; 65: 21-26.
9. Banzett R, O'Donnell CR, Guilfoyle TE, et al. Multidimensional Dyspnoea Profile (MDP): an instrument for laboratory and clinical research. Eur Respir J 2015; 45: 1681-1691.
10. Lansing R, Gracely RH, Banzett RB. The multiple dimensions of dyspnoea: review and hypothesis. Respir Physiol Neurobiol 2009; 167: 53-60.
11. Meek PM, Banzett R, Parshall MB, et al. Reliability and validity of the Multidimensional Dyspnoea Profile. Chest 2012; 141: 1546-1553.
12. Parshall MB, Meek PM, Sklar D, et al. Test-retest reliability of Multidimensional Dyspnoea Profile recall ratings in the emergency department: a prospective, longitudinal study. BMC Emerg Med 2012; 12: 6.
13. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of COPD. www.goldcopd.org Date last accessed: March 2, 2016.
14. Folstein M, Folstein S, McHugh P. "Mini-mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
15. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
16. MacIntyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720-735.
17. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511-522.
18. American Thoracic Society Statement. Guidelines for the six minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
19. Holland AE, Spruit MA, Troosters T, et al. An Official European Respiratory Society/American Thoracic Society technical standard: field walking tests in respiratory disease. Eur Respir J 2014; 44: 1428-1446.
20. Zigmond A, Snaith R. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361-370.
21. Task Force on Surveillance for Respirator Hazards in the Occupational Setting. Surveillance for respiratory hazards in the occupational setting. ATS News 1982; 126: 952-956.
22. Schünemann HJ, Goldstein R, Mador MJ, et al. A randomised trial to evaluate the self administered standardised chronic respiratory questionnaire. Eur Respir J 2005; 25: 31-40.
23. Yorke J, Spencer LG, Duck A, et al. Cross-Atlantic modification and validation of the A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF-cA). BMJ Open Respir Res 2014; 1: e000024.
24. Banzett RB, Pedersen SH, Schwartzstein RM, et al. The affective dimension of dyspnea: air hunger is more unpleasant than work/effort. Am J Respir Crit Care Med 2008; 177: 1384-1390.
25. Meng XL, Rosenthal R, Rubin DB. Comparing correlated correlation coefficients. Psychol Bull 1992; 111: 172-175.
26. Crisafulli E, Clini EM. Measures of dyspnea in pulmonary rehabilitation. Multidiscip Respir Med 2010; 5: 202-210.
27. Puhan MA, Frey M, Büchi S, et al. The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes 2008; 6: 46.
28. Schünemann HJ, Puhan M, Goldstein R, et al. Measurement properties and interpretability of the Chronic Respiratory Disease Questionnaire. COPD 2005; 2: 81-89.
29. Puhan MA, Mador M, Held U, et al. Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J 2008; 32: 637-643.
30. O'Donnell DE, Webb KA, Neder AJ. Lung hyperinflation in COPD: applying physiology to clinical practice. COPD Res Practice 2015; 1: 4.
31. Satake M, Shioya T, Uemura S, et al. Dynamic hyperinflation and dyspnoea during the six minute walk test in stable chronic obstructive pulmonary disease patients. Int J Chron Obstruct Pulmon Dis 2015; 10: 153-158.
32. Chen R, Lin l, Tian JW, et al. Predictors of dynamic hyperinflation during the 6-minute walk test in stable chronic obstructive pulmonary disease patients. J Thorac Dis 2015; 7: 1142-1150.
33. Silva CS, Nogueira FR, Porto EF, et al. Dynamic hyperinflation during activities of daily living in COPD patients. Chron Respir Dis 2015; 12: 189-196.
34. Garcia-Rio F, Lores V, Mediano O, et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009; 180: 506-512.
35. Lahaije AJMC, van Hevoort HAC, Dekhuijzen PNR, et al. Physiologic limitations during daily life activities in COPD patients. Respir Med 2010; 104: 1152-1159.
36. O'Donnell C, Bankier A, Stiebellehner L, et al. Comparison of plethysmograghic and helium dilution lung volumes. Which is best for COPD? Chest; 2010; 137: 1108-1115.
37. Fredrickson BL. Extracting meaning from past affective experiences: the importance of peaks, ends and specific emotions. Cogn Emot 2000; 14: 577-606.
38. Stone AA, Schwartz JE, Broderick JE, et al. Variability of momentary pain predicts recall of weekly pain: a consequence of the peak (or salience) memory heuristic. Pers Soc Psychol Bull 2005; 31: 1340-1346.
39. Morelot-Panzini C, Gilet H, Aguilaniu B, et al. Real-life assessment of the multidimensional nature of dyspnoea in COPD outpatients. Eur Respir J 2016; 47: 1668-1679.
40. Banzett RB, O'Donnell CR. Should we measure dyspnoea in everyone? Eur Respir J 2014; 43: 1547-1550.
41. Yorke J, Lloyd-Williams M, Smith Blackhall F, et al. Management of the respiratory distress symptom cluster in lung cancer: a randomised controlled feasibility trial. Support Care Cancer 2015; 23: 3373-3384.
42. Johnson MJ, Bland JM, Oxberry SG, et al. Clinically important differences in the intensity of chronic refractory breathlessness. J Pain Symptom Manage 2013; 46: 957-963.